NeuroOne Medical Technologies Corporation (NMTC) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time NMTC price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 20.4 Oversold
Market Cap $13.3M
Volume 39.8K
Fundamentals — 10-Q Q2 2026
Revenue $4.8M
Net Income $-3.8M
EPS $-0.47
Gross Margin 53.8%
Operating Margin -86.3%
Net Margin -80.3%
P/E Ratio -3.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director | Sell | 15,363 | $0.74 | $11,369 | 2026 Mar 30 |
| Christianson Mark | Business Development Director | Sell | 917 | $0.80 | $734 | 2026 Mar 13 |
| Christianson Mark | Business Development Director | Sell | 13,720 | $0.80 | $10,976 | 2026 Mar 11 |
| Wambeke David J. | Chief Business Officer | Buy | 1,000,000 | $0.67 | $670,400 | 2026 Mar 1 |
| Christianson Mark | Business Development Director | Sell | 30,000 | $0.74 | $22,200 | 2025 Sep 5 |
| Christianson Mark | Business Development Director | Sell | 10,000 | $0.58 | $5,800 | 2025 Jun 4 |
| Christianson Mark | Business Development Director | Sell | 8,981 | $0.62 | $5,569 | 2025 May 22 |
| Christianson Mark | Business Development Director | Sell | 11,019 | $0.67 | $7,353 | 2025 May 20 |
| McClurg Ronald W. | Chief Financial Officer | Buy | 200,000 | $0.50 | $100,000 | 2025 Apr 4 |
| Rosa David A | CEO and President | Buy | 100,000 | $0.50 | $50,000 | 2025 Apr 4 |
| Christianson Mark | Business Development Director | Sell | 2,189 | $0.88 | $1,926 | 2024 Jun 6 |
| Christianson Mark | Business Development Director | Sell | 25,800 | $0.88 | $22,704 | 2024 Jun 5 |
| Christianson Mark | Business Development Director | Sell | 38,293 | $1.44 | $55,155 | 2023 Dec 27 |
| Christianson Mark | Business Development Director | Sell | 11,707 | $1.40 | $16,390 | 2023 Dec 22 |
| Volker Christopher | Chief Operating Officer | Buy | 75,000 | $1.40 | $105,000 | 2023 Dec 21 |
| McClurg Ronald W. | Chief Financial Officer | Buy | 50,900 | $0.98 | $49,882 | 2023 Sep 13 |
| Christianson Mark | Business Development Director | Sell | 26,500 | $1.51 | $40,079 | 2023 Mar 23 |
| McClurg Ronald W. | Chief Financial Officer | Buy | 10,000 | $1.02 | $10,200 | 2022 Jun 15 |
| McClurg Ronald W. | Chief Financial Officer | Buy | 14,000 | $1.06 | $14,840 | 2022 Jun 10 |
| McClurg Ronald W. | Chief Financial Officer | Buy | 28,000 | $0.90 | $25,165 | 2022 May 24 |
Take NMTC further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NMTC in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when NeuroOne Medical Technologies Corporation next reports.
Set alerts on NMTC
Get notified when NeuroOne Medical Technologies Corporation hits your price targets or technical conditions are met.
Get Started Free